Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease

Y Zhou, WM Song, PS Andhey, A Swain, T Levy… - Nature medicine, 2020 - nature.com
Glia have been implicated in Alzheimer's disease (AD) pathogenesis. Variants of the
microglia receptor triggering receptor expressed on myeloid cells 2 (TREM2) increase AD …

Identification of senescent, TREM2-expressing microglia in aging and Alzheimer's disease model mouse brain

N Rachmian, S Medina, U Cherqui, H Akiva… - Nature …, 2024 - nature.com
Alzheimer's disease (AD) and dementia in general are age-related diseases with multiple
contributing factors, including brain inflammation. Microglia, and specifically those …

[HTML][HTML] TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease

SH Lee, MG Rezzonico, BA Friedman, MH Huntley… - Cell Reports, 2021 - cell.com
Non-neuronal responses in neurodegenerative disease have received increasing attention
as important contributors to disease pathogenesis and progression. Here we utilize single …

[HTML][HTML] Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease

A McQuade, YJ Kang, J Hasselmann… - Nature …, 2020 - nature.com
The discovery of TREM2 as a myeloid-specific Alzheimer's disease (AD) risk gene has
accelerated research into the role of microglia in AD. While TREM2 mouse models have …

[HTML][HTML] TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function

Q Cheng, J Danao, S Talreja, P Wen, J Yin… - Journal of Biological …, 2018 - ASBMB
Triggering receptor expressed on myeloid cells 2 (TREM2) is an orphan immune receptor
expressed on cells of myeloid lineage such as macrophages and microglia. The rare variant …

TREM2 function in Alzheimer's disease and neurodegeneration

JD Ulrich, DM Holtzman - ACS chemical neuroscience, 2016 - ACS Publications
Alzheimer's disease (AD), the most common cause of dementia in the elderly, is a complex
neurodegenerative disease marked by the appearance of amyloid-β (Aβ) plaques and …

[HTML][HTML] The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans

X Xiang, TM Piers, B Wefers, K Zhu, A Mallach… - Molecular …, 2018 - Springer
Abstract Background The R47H variant of the Triggering Receptor Expressed on Myeloid
cells 2 (TREM2) significantly increases the risk for late onset Alzheimer's disease. Mouse …

TREM2 in Alzheimer's disease

T Jiang, JT Yu, XC Zhu, L Tan - Molecular neurobiology, 2013 - Springer
Recent works have demonstrated a rare functional variant (R47H) in triggering receptor
expressed on myeloid cells (TREM) 2 gene, encoding TREM2 protein, increase …

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models

TR Jay, CM Miller, PJ Cheng, LC Graham… - Journal of Experimental …, 2015 - rupress.org
Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for
Alzheimer's disease (AD) and other neurodegenerative diseases. However, the cell types …

[HTML][HTML] TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation

M Moutinho, I Coronel, AP Tsai, GV Di Prisco… - Genome Medicine, 2023 - Springer
Background TREM2 is a transmembrane receptor expressed by myeloid cells and acts to
regulate their immune response. TREM2 governs the response of microglia to amyloid and …